S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Options Trading Plan–Perfect For Beginners (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Options Trading Plan–Perfect For Beginners (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
Options Trading Plan–Perfect For Beginners (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Options Trading Plan–Perfect For Beginners (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Options Trading Plan–Perfect For Beginners (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
Options Trading Plan–Perfect For Beginners (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Options Trading Plan–Perfect For Beginners (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Options Trading Plan–Perfect For Beginners (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
Options Trading Plan–Perfect For Beginners (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Options Trading Plan–Perfect For Beginners (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Options Trading Plan–Perfect For Beginners (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
Options Trading Plan–Perfect For Beginners (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
NASDAQ:EDSA

Edesa Biotech (EDSA) Earnings Date, Estimates & Call Transcripts

$0.85
0.00 (0.00%)
(As of 09/25/2023 ET)
Compare
Today's Range
$0.84
▼
$0.89
50-Day Range
$0.77
▼
$0.99
52-Week Range
$0.76
▼
$2.81
Volume
10,006 shs
Average Volume
34,118 shs
Market Capitalization
$17.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Dec. 15Estimated
Actual EPS
(Aug. 9)
-$0.10 Beat By $0.07
Consensus EPS
(Aug. 9)
-$0.17
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

EDSA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EDSA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Edesa Biotech Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20232($0.21)($0.17)($0.19)
Q2 20232($0.24)($0.13)($0.19)
Q3 20232($0.22)($0.12)($0.17)
Q4 20233($0.23)($0.10)($0.14)
FY 20239($0.90)($0.52)($0.69)

EDSA Earnings Date and Information

Edesa Biotech last posted its earnings results on August 9th, 2023. The reported ($0.10) earnings per share for the quarter, topping the consensus estimate of ($0.17) by $0.07. Edesa Biotech has generated ($0.36) earnings per share over the last year (($0.36) diluted earnings per share). Earnings for Edesa Biotech are expected to decrease in the coming year, from ($0.44) to ($1.65) per share. Edesa Biotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, December 15th, 2023 based off prior year's report dates.

Edesa Biotech Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
12/15/2023
Estimated)		------- 
8/9/2023Q2 2023($0.17)($0.10)+$0.07($0.10)--
5/11/2023Q2 2023($0.17)($0.12)+$0.05($0.12)--
2/10/2023Q1 2023($0.19)($0.13)+$0.06($0.13)--
12/16/2022Q4 2022($0.40)($0.01)+$0.39($0.01)--
8/12/2022Q3 2022($0.36)($0.37)($0.01)($0.37)--
5/13/2022Q2 2022($0.37)($0.33)+$0.04($0.33)--
2/14/2022Q1 2022($0.40)($0.33)+$0.07($0.33)--
12/28/2021Q4($0.3670)($0.27)+$0.0970($0.27)--
8/12/2021-($0.32)($0.36)($0.04)($0.36)--
5/14/2021Q2 2021($0.30)($0.19)+$0.11($0.19)--
2/15/2021Q1($0.19)($0.26)($0.07)($0.26)--
12/10/2020Q4($0.2050)($0.22)($0.0150)($0.22)--












Edesa Biotech Earnings - Frequently Asked Questions

When is Edesa Biotech's earnings date?

Edesa Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, December 15th, 2023 based off last year's report dates. Learn more on EDSA's earnings history.

Did Edesa Biotech beat their earnings estimates last quarter?

In the previous quarter, Edesa Biotech (NASDAQ:EDSA) reported ($0.10) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.17) by $0.07. Learn more on analysts' earnings estimate vs. EDSA's actual earnings.

How much revenue does Edesa Biotech generate each year?

Edesa Biotech (NASDAQ:EDSA) has a recorded annual revenue of $330,000.00.

How much profit does Edesa Biotech generate each year?

Edesa Biotech (NASDAQ:EDSA) has a recorded net income of -$17.55 million. EDSA has generated -$0.36 earnings per share over the last four quarters.

What is Edesa Biotech's EPS forecast for next year?

Edesa Biotech's earnings are expected to decrease from ($0.44) per share to ($1.65) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:EDSA) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -